Skip to content

Opioid substitution therapy, especially in combination with needle exchange, reduces transmission of hepatitis C

Opioid substitution therapy, especially in combination with needle exchange, reduces transmission of hepatitis C

Studies continue to support tenofovir alafenamide combination pill as it nears US approval

Hepatitis C-related mortality continues to increase in the US

At least 25,000 people in the US may now be using PrEP

Abacavir/lamivudine could be driving liver damage in ART-treated patients with HIV/HCV co-infection

HIV attachment inhibitor BMS-663068 matches atazanavir in phase 2b study

Interferon-free treatment works well for people who inject drugs, but barriers to access remain

Affordable Care Act coverage improves chances of viral suppression for Americans with HIV

No transmission of integrase inhibitor-resistant HIV seen in California patients